Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Bowen Sun, Geng Wang, Huidong Liu, Pian Liu, Waleed O. Twal, Hiuwing Cheung, Steven L. Carroll, Stephen P. Ethier, Emily E. Mevers, Jon Clardy, Thomas Roberts, Changbin Chen, Qian Li, Lanfeng Wang, Meixiang Yang, Jean J. Zhao, Qi Wang
Published May 8, 2018 · Vol. 9, No. 35 · pp. 23878-23889
Lisa Mäder, Anna E. Blank, David Capper, Janina Jansong, Peter Baumgarten, Naita M. Wirsik, Cornelia Zachskorn, Jakob Ehlers, Michael Seifert, Barbara Klink, Stefan Liebner, Simone Niclou, Ulrike Naumann, Patrick N. Harter, Michel Mittelbronn
Published May 8, 2018 · Vol. 9, No. 35 · pp. 24041-24053
Candelaria Bracalente, Adriana R. Rinflerch, Irene L. Ibañez, Francisco M. GarcÃa, Victoria Volonteri, Gastón N. Galimberti, Fabio Klamt, Hebe Durán
Published May 8, 2018 · Vol. 9, No. 35 · pp. 24097-24108